Domov › Malobuněčný rakovina plic › Pennsylvania
Klinické štúdie Malobuněčný rakovina plic v štáte Pennsylvania
15 štúdií pre Malobuněčný rakovina plic hľadá účastníkov v zariadeniach v štáte Pennsylvania.
Mestá v štáte Pennsylvania
Oficiálny text štúdie (anglicky)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center, Pittsburgh
- WellSpan York Cancer Center, York
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia
Prebieha náborFáza 1
Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
- AHN Cancer Institute - Allegheny General, Pittsburgh
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07472517DESTINY-PANTUMOUR04
- Research Site, Philadelphia
Prebieha náborObservačná štúdia
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- St. Lukes University Hospital /ID# 280204, Bethlehem
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07365241A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Consultants in Medical Oncology and Hematology, Broomall
- Alliance Cancer Specialists, Media
- Allegheny General Hospital, Pittsburgh
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07218146AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Philadelphia
Prebieha náborFáza 1/2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT06712355Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
- Fox Chase Cancer Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
- Guthrie, Sayre
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT07057791A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 7. 2026 · NCT07174583Tempus Small Cell Lung Cancer Observational Study (Sculptor)
- Cancer Care Association of York, York
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 6. 2026 · NCT05257551Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
- Fox Chase Cancer Center, Philadelphia
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT05800587Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 3. 2026 · NCT06681220Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 2. 2026 · NCT07030257VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Cancer Care Associates of York (site 206), York
Prebieha náborFáza 1/2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 12. 2025 · NCT03556228Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.